Optimizing Pharmaceutical Synthesis: The Value of High-Purity 2-Chloro-3-methylpyridine
The pharmaceutical industry constantly seeks efficient and reliable chemical building blocks to develop innovative drugs. Among these, 2-Chloro-3-methylpyridine (CAS: 18368-76-8) plays a significant role as a versatile intermediate. For R&D scientists and procurement specialists, understanding the value of this compound and its reliable sourcing is crucial for successful drug development.
2-Chloro-3-methylpyridine: A Key Pharmaceutical Intermediate
2-Chloro-3-methylpyridine, also identified as 2-Chloro-3-picoline, is a liquid chemical intermediate characterized by its colorless to light yellow appearance and an assay typically reaching ≥98.0%. Its primary importance in the pharmaceutical sector stems from its application as a precursor in the synthesis of Active Pharmaceutical Ingredients (APIs). A notable example is its use in the production of Lumacaftor, a drug that targets cystic fibrosis by improving the transport of CFTR protein. Its chemical structure also lends itself to the synthesis of other medicinally important compounds.
Enhancing Pharmaceutical Development
The use of high-purity 2-Chloro-3-methylpyridine offers several advantages in pharmaceutical synthesis:
- Synthetic Efficiency: The well-defined chemical structure and high purity of this intermediate ensure predictable reaction outcomes, streamlining the synthesis process and potentially reducing by-product formation.
- API Quality: Using a high-grade intermediate like 2-Chloro-3-methylpyridine is essential for achieving the required purity and efficacy of the final API, meeting stringent regulatory standards.
- Drug Discovery: its versatility makes it a valuable tool in drug discovery and development, enabling the creation of novel molecular entities with therapeutic potential.
Strategic Sourcing for Pharmaceutical Needs
When looking to buy 2-Chloro-3-methylpyridine for your pharmaceutical projects, consider the following:
- Supplier Reputation: Choose manufacturers and suppliers with a proven track record in providing pharmaceutical-grade intermediates. A strong presence in China can offer significant advantages in terms of cost and accessibility.
- Quality Assurance: Verify that suppliers can provide comprehensive documentation, including Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS), to confirm purity and safe handling procedures.
- Pricing and Availability: Research the market price for 2-Chloro-3-methylpyridine and engage with suppliers who offer competitive pricing for R&D quantities as well as bulk commercial orders.
- Technical Support: A knowledgeable supplier can offer valuable insights into the compound's applications and synthesis, supporting your research efforts.
NINGBO INNO PHARMCHEM CO.,LTD. – Your Pharmaceutical Partner
NINGBO INNO PHARMCHEM CO.,LTD. is a dedicated supplier of 2-Chloro-3-methylpyridine, committed to supporting the pharmaceutical industry. We understand the critical importance of purity and reliability in drug development. Our high-quality intermediate, sourced from reputable manufacturers, ensures your synthesis processes are efficient and your final products meet the highest standards. As a trusted manufacturer in China, we offer competitive pricing and responsive service. To discuss your needs or to request a quote for 2-Chloro-3-methylpyridine, please contact us.
Perspectives & Insights
Quantum Pioneer 24
“API Quality: Using a high-grade intermediate like 2-Chloro-3-methylpyridine is essential for achieving the required purity and efficacy of the final API, meeting stringent regulatory standards.”
Bio Explorer X
“Drug Discovery: its versatility makes it a valuable tool in drug discovery and development, enabling the creation of novel molecular entities with therapeutic potential.”
Nano Catalyst AI
“Strategic Sourcing for Pharmaceutical Needs When looking to buy 2-Chloro-3-methylpyridine for your pharmaceutical projects, consider the following: Supplier Reputation: Choose manufacturers and suppliers with a proven track record in providing pharmaceutical-grade intermediates.”